Logo.png
Vyant Bio Announces Investor Conference Call and Webcast for the First Quarter 2022
May 10, 2022 16:01 ET | Vyant Bio, Inc.
CHERRY HILL, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Vyant Bio Issues Letter to Shareholders
March 01, 2022 08:30 ET | Vyant Bio, Inc.
Cherry Hill, NJ, March 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, the “Company”) (Nadsaq:VYNT), is an innovative biotechnology company focused on identifying unique biological...
Logo.png
Vyant Bio to Present at The Benchmark Company Discovery One-on-One Investor Conference
November 29, 2021 09:15 ET | Vyant Bio, Inc.
Cherry Hill, N.J.,, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, the “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
Logo.png
Vyant Bio Announces Investor Conference Call and Webcast for the Third Quarter 2021
November 09, 2021 09:15 ET | Vyant Bio, Inc.
CHERRY HILL, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
Logo.png
Vyant Bio Announces Robert T. Fremeau, Jr. Ph.D. as Chief Scientific Officer
October 26, 2021 08:00 ET | Vyant Bio, Inc.
Cherry Hill, N.J., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company identifying small and large molecule...
Logo.png
Vyant Bio Reports First Quarter 2021 Results and Provides Strategic Business Update
May 17, 2021 17:15 ET | Vyant Bio, Inc.
Cherry Hill, N.J., May 17, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (the “Company”) (Nasdaq: VYNT), is an innovative biotechnology company focused on partnering with pharmaceutical and other...
Logo.png
Vyant Bio Announces Investor Conference Call and Webcast for First Quarter 2021
May 13, 2021 08:00 ET | Vyant Bio, Inc.
CHERRY HILL, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is focused on integrating human-powered scientific and technology-based systems to...
Logo.png
Vyant Bio Announces Newly Appointed Board of Directors
April 05, 2021 16:20 ET | Vyant Bio, Inc.
CHERRY HILL, N.J., April 05, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (the “Company”) (Nasdaq: VYNT), is a new force in drug discovery, focused on integrating human-powered scientific and...
Logo.png
Cancer Genetics and StemoniX Announce Merger Closing
March 31, 2021 06:30 ET | Cancer Genetics, Inc.
Cancer Genetics, Inc. Renamed to Vyant Bio, Inc. Vyant Bio, Inc. will begin trading on Nasdaq under the symbol VYNT CHERRY HILL, N.J., March 31, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc....
Old Logo.png
Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX
March 25, 2021 09:15 ET | Cancer Genetics, Inc.
Combined entity creates an innovative platform to de-risk and accelerate the discovery and development of preclinical and clinical pipelines with biopharma partners as well as the proprietary pipeline...